Quantitative Mri Characterization of Brain Abnormalities in DE NOVO Parkinsonian Patients
暂无分享,去创建一个
Julyan Arbel | Michel Dojat | Florence Forbes | Alexis Arnaud | Veronica Munoz Ramirez | F. Forbes | M. Dojat | V. Ramírez | A. Arnaud | Julyan Arbel
[1] A. Stefani,et al. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. , 2010, Brain : a journal of neurology.
[2] Marie Vidailhet,et al. A review of the use of magnetic resonance imaging in Parkinson’s disease , 2014, Therapeutic advances in neurological disorders.
[3] Marios Politis,et al. Neuroimaging in Parkinson disease: from research setting to clinical practice , 2014, Nature Reviews Neurology.
[4] J. Klein,et al. Neuroimaging in pre-motor Parkinson's disease☆ , 2017, NeuroImage: Clinical.
[5] Daniel E. Huddleston,et al. Multimodal Imaging Signatures of Parkinson's Disease , 2016, Front. Neurosci..
[6] M. Mallar Chakravarty,et al. Multi-contrast unbiased MRI atlas of a Parkinson’s disease population , 2015, International Journal of Computer Assisted Radiology and Surgery.
[7] Martin Styner,et al. Combined R2* and Diffusion Tensor Imaging Changes in the Substantia Nigra in Parkinson's Disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[8] Dorothee P. Auer,et al. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis☆ , 2013, NeuroImage: Clinical.
[9] Florence Forbes,et al. Fully Automatic Lesion Localization and Characterization: Application to Brain Tumors Using Multiparametric Quantitative MRI Data , 2018, IEEE Transactions on Medical Imaging.
[10] Florence Forbes,et al. A new family of multivariate heavy-tailed distributions with variable marginal amounts of tailweight: application to robust clustering , 2013, Statistics and Computing.
[11] Klaus P. Ebmeier,et al. Exploring variability in basal ganglia connectivity with functional MRI in healthy aging , 2018, Brain Imaging and Behavior.